Acibadem Healthcare Group
Acibadem Healthcare Group scored 75/100 on Panya's 11-signal vendor rubric. Each signal is scored 0 to 100, the methodology is public, and our affiliate posture is flat-fee — never pay-to-rank. Below is the full per-signal breakdown.
- COA on every lot85
- Cold-chain verified29-hospital JCI group pharmacy chain90
- Rx legality (TITCK)95
- Compound identity6 JCI-accredited Istanbul hospitals90
- Dose accuracyendocrinology + dietetics + psych obesity team85
- Endotoxin testing80
- Refund posture65
- Channel clarityIstanbul anchor, intl-patient program90
- Support qualityintl-patient services, EN/DE/AR/RU desk85
- Price transparencybariatric package public; GLP-1 by consult65
- Longitudinal retentionobesity center multi-disciplinary follow-through70
TITCK approval pending as of April 2026. Tirzepatide not currently available through Turkish private channel. Cross-border or wait-and-see.
Established T2D channel. Off-label weight common at private hospitals. Cheapest legitimate Turkish semaglutide route.
TITCK-approved. Acibadem and Anadolu hospital chains stock; medical-tourism program format. Strong EU price arbitrage.
The 11-signal rubric is public.
Identity, dose accuracy, COA, cold-chain, Rx legality, compound identity, endotoxin testing, refund posture, channel clarity, support quality, price transparency, longitudinal retention. Each scored 0 to 100. Vendors that fail our floor are silently filtered out — they don't appear in our match flow at all.
If Acibadem Healthcare Group wants to dispute or update this score, contact partner@panya.health. Score updates are recorded on this page with a public changelog.
Want a match for your situation?
Take the 2-minute quiz. We'll match you against this and the other vendors in your region — based on your dose, urgency, and budget.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.